Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Mixed options sentiment in Novo Nordisk (NVO), with shares up 62c, or 1.15%, near $54.92. Options volume relatively light with 49k contracts traded and calls le...
Key Points Eli Lilly and Novo Nordisk are both preparing to launch obesity pills in the U.S. next year. Lilly expects results from a head-to-head trial of its...
Novo Nordisk (NVO) CEO Maziar Mike Doustdar is calling workers back to the office as the Ozempic maker struggles to catch up with Eli Lilly (LLY) in the obesity...
Analyst ratings
50%
of 32 ratingsMore NVO News
Novo Nordisk (NVO) announced on Thursday that all employees must return to the office. This move comes as the new CEO aims to speed up decision-making and enha...
Danish pharmaceutical giant Novo Nordisk (NVO) is demanding that employees return to the office full-time after announcing nearly 10,000 job cuts. Elevate Your...
Analyst Sachin Jain of Bank of America Securities maintained a Hold rating on Novo Nordisk, with a price target of DKK375.00. Elevate Your Investing Strategy: T...
...
After Novo Nordisk (NVO) announced an EBIT guide cut on restructuring costs, with the EBIT growth guidance range lowered from 10%-16% to 4%-10%, BofA noted that...
Prescription drugs Job market Food & health See all topics Follow London — Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people...
Inside the price war between Ozempic and other weight loss drugs Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday i...
